These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2977856)

  • 21. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
    Gresele P; Arnout J; Deckmyn H; Huybrechts E; Pieters G; Vermylen J
    J Clin Invest; 1987 Nov; 80(5):1435-45. PubMed ID: 2960694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.
    Cook JA; Wise WC; Halushka PV
    J Clin Invest; 1980 Jan; 65(1):227-30. PubMed ID: 7350199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teratogenicity of three substituted 4-biphenyls in the rat as a result of the chemical breakdown and possible metabolism of a thromboxane A2-receptor blocker.
    Sutherland MF; Parkinson MM; Hallett P
    Teratology; 1989 Jun; 39(6):537-45. PubMed ID: 2528217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostaglandin endoperoxide and thromboxane A2 analogs.
    Wilson NH; Jones RL
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():393-425. PubMed ID: 2992245
    [No Abstract]   [Full Text] [Related]  

  • 25. Role of thromboxane in the pulmonary response to pulmonary microembolization.
    Garcia Szabo RR; Minnear FL; Bizios R; Johnson A; Malik AB
    Chest; 1983 May; 83(5 Suppl):76S-78S. PubMed ID: 6682370
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathophysiological role of thromboxane A2 and pharmacological approaches to its inhibition.
    Patscheke H; Hornberger W; Zehender H
    Z Kardiol; 1990; 79 Suppl 3():151-4. PubMed ID: 2099038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--II. Pharmacological effects in vivo and ex vivo.
    De Clerck F; Beetens J; Van de Water A; Vercammen E; Janssen PA
    Thromb Haemost; 1989 Feb; 61(1):43-9. PubMed ID: 2526385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE; Kochel PJ; Saussy DL; Halushka PV
    Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual inhibition of thromboxane A2 synthesis and thromboxane A2/prostaglandin endoperoxide receptors by ridogrel: anti-thrombotic effect in vivo in rat mesenteric arteries.
    Bourgain RH; Andries R; Decuyper K; De Clerck F
    J Lipid Mediat; 1991; 3(1):3-11. PubMed ID: 1837488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased platelet thromboxane synthesis in diabetes mellitus.
    Halushka PV; Rogers RC; Loadholt CB; Colwell JA
    J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Suppression of platelet aggregation as a result of two-component inhibition of a polyenzyme system of thromboxane synthesis].
    Varfolomeev SD; Lakin KM; Mevkh AT; Novikova NV; Rukazenkov IuZ
    Dokl Akad Nauk SSSR; 1985; 282(1):194-6. PubMed ID: 3928305
    [No Abstract]   [Full Text] [Related]  

  • 32. Photoaffinity labelling and isoelectric focusing of the human platelet thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor.
    Mais DE; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():168-71. PubMed ID: 2526465
    [No Abstract]   [Full Text] [Related]  

  • 33. Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets.
    Gresele P; Deckmyn H; Arnout J; Nenci GG; Vermylen J
    Thromb Haemost; 1989 Jun; 61(3):479-84. PubMed ID: 2552606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists.
    Dickinson RP; Dack KN; Long CJ; Steele J
    J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective blockade of thromboxane A2 synthesis during experimental E coli bacteremia in the goat. Effects on hemodynamics and lung water.
    Harlan J; Winn R; Weaver J; Hildebrandt J; Harker L
    Chest; 1983 May; 83(5 Suppl):75S-76S. PubMed ID: 6340988
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolongation of experimental cardiac allograft survival with thromboxane-related drugs.
    Foegh ML; Khirabadi B; Ramwell PW
    Transplantation; 1985 Aug; 40(2):124-5. PubMed ID: 3161224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotics from basidiomycetes. XXXVIII. 2-Methoxy-5-methyl-1,4-benzoquinone, a thromboxane A2 receptor antagonist from Lentinus adhaerens.
    Lauer U; Anke T; Hansske F
    J Antibiot (Tokyo); 1991 Jan; 44(1):59-65. PubMed ID: 1825820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of imidazole-analogues on bone resorption in vitro: a suggested role for thromboxane A2.
    Heersche JN; Jez DH
    Prostaglandins; 1981 Mar; 21(3):401-11. PubMed ID: 7232765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prostaglandin regulation of colonic blood flow in rabbit colitis.
    Brown JA; Zipser RD
    Gastroenterology; 1987 Jan; 92(1):54-9. PubMed ID: 2946624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of carbenoxolone on the gastric mucosal prostaglandin and thromboxane system.
    Peskar BM
    Acta Gastroenterol Belg; 1983; 46(9-10):429-36. PubMed ID: 6324520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.